| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.3 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.047 | 0.3 |
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | -0.031 | 0.3 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.3 |
| mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | -0.066 | 0.3 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.044 | 0.3 |
| mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.3 |